• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Gritstone Oncology

Bankruptcy
Biotech

Gritstone files for bankruptcy in hope of keeping R&D afloat

Gritstone may have left no stone unturned when it came to searching for a financial rescue, but the biotech has decided all roads lead to bankruptcy.
James Waldron Oct 10, 2024 6:36am
money time

Cash-strapped Gritstone starts search for strategic alternatives

Oct 1, 2024 10:07am
plan B fail reroute road path trail miss

Gritstone ground down by phase 2 cancer vaccine fail

Apr 2, 2024 5:09am
time clock decade wait delay

Gritstone lays off 40% of team after delaying COVID vax trial

Feb 29, 2024 4:05pm
A 3D rendering of the COVID-19 virus SARS-CoV-2 Most of the virus particles are blue with a bright red one in the center

Gritstone gets $433M in BARDA funds to trial mRNA COVID-19 shot

Sep 28, 2023 5:54am
unlabeled vaccine

Gritstone taps Genevant to power up infectious disease vaccines

Aug 15, 2023 10:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings